ChatGPT for health care providers: Can the AI chatbot make the professionals’ jobs easier?
In addition to writing articles, songs and code in mere seconds, ChatGPT could potentially make its way into your doctor’s office — if it hasn’t already.
Announcing the results of the 2026 INFORMS Board of Directors election and the new board for 2027.
INFORMS has named 12 distinguished leaders as the 2026 class of INFORMS Fellows, one of the highest honors in the profession.
America’s vaccine system faces more than a crisis of public confidence. It faces a potential operational breakdown. Changing vaccine recommendations without accounting for manufacturing capacity, supply chains, distribution networks and patient access risks turning uncertainty into shortages, delays and declining vaccination rates.
An audio journey of how data and analytics save lives, save money and solve problems.

Jeff Cohen
Chief Strategy Officer
INFORMS
Catonsville, MD
[email protected]
443-757-3565
Explore our resources for multiple topics including:
In addition to writing articles, songs and code in mere seconds, ChatGPT could potentially make its way into your doctor’s office — if it hasn’t already.
Urban disasters bring uncertainties to society, urban transportation systems, and businesses. In a new study, researchers examined urban emergencies such as terrorist attacks and subway shutdowns to compare how a traditional taxi system and a ridesharing platform performed afterwards. The study found that the ridesharing platform significantly outperformed the taxi system in coping with emergencies, largely due to the benefits of technology.
The search giant faces tough challenges as it squares off against Microsoft and its newly re-emergent search engine powered by OpenAI's GPT technology.
ChatGPT, the artificial intelligence chatbot that was released by OpenAI in December 2022, is known for its ability to answer questions and provide detailed information in seconds — all in a clear, conversational way.
In October 2022, the U.S. Food and Drug Administration (FDA) announced a shortage of amphetamine mixed salts—a drug category that includes Adderall, the stimulant medication often used to treat attention-deficit/hyperactivity disorder (ADHD).

OR/MS Today is the INFORMS member magazine that shares the latest research and best practices in operations research, analytics and the management sciences.
Access OR/MS Today Magazine
Analytics magazine showcases articles and research reports based on big data, AI, machine learning, data analytics and other new-age technologies.
Access Analytics Magazine